 Connection
Meredith Clement to Pre-Exposure Prophylaxis
This is a "connection" page, showing publications Meredith Clement has written about Pre-Exposure Prophylaxis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
8.237 |
|
|
|
-
Irie WC, Corneli A, Perry B, Kelsey C, Bickham J, Davenport T, Naresh A, Holman S, Clement M. Start the Conversation: Development of a Training Program to Build OB/GYN Resident Capacity for PrEP Prescribing in Routine Care. J Int Assoc Provid AIDS Care. 2026 Jan-Dec; 25:23259582261488339.
Score: 0.756
-
Clement ME, Thomas J, Kelsey C, Jagneaux T, O'Neal C, Lim S, Widman S, Marcus J, Okeke NL, Wilson S. HEalth Record Optimization for Identifying Candidates for HIV PRe-Exposure Prophylaxis: A Community-Informed Approach to Model Development. AIDS Patient Care STDS. 2025 07; 39(7):266-272.
Score: 0.696
-
Clement ME, Perry B, McKenna K, Beckford J, Davenport T, Murray E, Magee V, Bickham JN, Siren J, Smith A, Lillis R, Corneli A. Identifying Implementation Strategies to Enhance HIV Pre-Exposure Prophylaxis Uptake Among Black Cisgender Women in New Orleans, Louisiana. AIDS Patient Care STDS. 2024 03; 38(3):144-150.
Score: 0.635
-
Lovett A, Luder R, Lillis RA, Butler I, Siren J, Gomez S, Kamis K, Obafemi O, Rowan SE, Baral S, Clement ME. Client Perspectives on the Development of a Rapid PrEP Initiative at a Sexual Health Center in New Orleans, Louisiana. J Int Assoc Provid AIDS Care. 2024 Jan-Dec; 23:23259582241258559.
Score: 0.628
-
Clement ME, Beckford J, Lovett A, Siren J, Adorno M, Legrand S, Bennett M, Taylor J, Hanlen-Rosado E, Perry B, Corneli A. Sexually Transmitted Infection Prevention Perspectives in Black Men Who Have Sex With Men Taking Preexposure Prophylaxis in New Orleans. Sex Transm Dis. 2024 02 01; 51(2):90-95.
Score: 0.626
-
Burns CM, Pung L, Witt D, Gao M, Sendak M, Balu S, Krakower D, Marcus JL, Okeke NL, Clement ME. Development of a Human Immunodeficiency Virus Risk Prediction Model Using Electronic Health Record Data From an Academic Health System in the Southern United States. Clin Infect Dis. 2023 01 13; 76(2):299-306.
Score: 0.587
-
Corneli A, Perry B, Taylor J, Beckford J, Molokwu N, Reif S, Wilson J, Gulden C, Bickham J, Siren J, Thompson W, Clement ME. HIV Prevention During the COVID-19 Pandemic: Sexual Activity and PrEP Use Among Black Same-Gender-Loving Men and Black Cisgender Women. AIDS Educ Prev. 2022 04; 34(2):142-157.
Score: 0.556
-
Lillis R, Beckford J, Fegley J, Siren J, Hinton B, Gomez S, Taylor SN, Butler I, Halperin J, Clement ME. Evaluation of an HIV Pre-Exposure Prophylaxis Referral System: From Sexual Health Center to Federally Qualified Health Center Pre-Exposure Prophylaxis Clinic. AIDS Patient Care STDS. 2021 09; 35(9):354-359.
Score: 0.534
-
Clement ME, Nicchitta M, Sun Y, Ellis A, Chakraborty H, McGee K, Eagle C, Frye J, Taylor D, Okeke NL, Johnston B, Seña AC, McKellar M. Preexposure Prophylaxis Outcomes in an Urban Community in North Carolina: Discontinuation of Care and Sexually Transmitted Infections. Sex Transm Dis. 2021 03 01; 48(3):183-188.
Score: 0.516
-
Clement ME, Kofron R, Landovitz RJ. Long-acting injectable cabotegravir for the prevention of HIV infection. Curr Opin HIV AIDS. 2020 01; 15(1):19-26.
Score: 0.476
-
Clement ME, Johnston BE, Eagle C, Taylor D, Rosengren AL, Goldstein BA, Seña AC. Advancing the HIV Pre-Exposure Prophylaxis Continuum: A Collaboration Between a Public Health Department and a Federally Qualified Health Center in the Southern United States. AIDS Patient Care STDS. 2019 08; 33(8):366-371.
Score: 0.459
-
Clement ME, Okeke NL, Munn T, Hunter M, Alexis K, Corneli A, Seña AC, McGee K, McKellar MS. Partnerships Between a University-Affiliated Clinic and Community-Based Organizations to Reach Black Men Who Have Sex With Men for PrEP Care. J Acquir Immune Defic Syndr. 2018 02 01; 77(2):e25-e27.
Score: 0.417
-
Clement ME, Seidelman J, Wu J, Alexis K, McGee K, Okeke NL, Samsa G, McKellar M. An educational initiative in response to identified PrEP prescribing needs among PCPs in the Southern U.S. AIDS Care. 2018 05; 30(5):650-655.
Score: 0.407
-
Llibre JM, Iniesta C, Tittle V, Clement M, Rivero Á, Armenteros-Yeguas I, Álvarez-López P, Ryan P, Arribas JR, Moreno S. Closing the PrEP access gap in Europe: a strategic framework for equity and innovation among difficult-to-reach populations. J Antimicrob Chemother. 2026 Feb 02; 81(3).
Score: 0.181
-
Irie WC, Nicol MR, Clement M, Bukusi EA, Bekker LG, Molina JM, Stewart J. Event-driven PrEP beyond cisgender men who have sex with men. Lancet HIV. 2025 Feb; 12(2):e143-e153.
Score: 0.168
-
Kelley CF, Acevedo-Quiñones M, Agwu AL, Avihingsanon A, Benson P, Blumenthal J, Brinson C, Brites C, Cahn P, Cantos VD, Clark J, Clement M, Creticos C, Crofoot G, Diaz RS, Doblecki-Lewis S, Gallardo-Cartagena JA, Gaur A, Grinsztejn B, Hassler S, Hinojosa JC, Hodge T, Kaplan R, Lacerda M, LaMarca A, Losso MH, Valdez Madruga J, Mayer KH, Mills A, Mounzer K, Ndlovu N, Novak RM, Perez Rios A, Phanuphak N, Ramgopal M, Ruane PJ, Sánchez J, Santos B, Schine P, Schreibman T, Spencer LY, Van Gerwen OT, Vasconcelos R, Vasquez JG, Zwane Z, Cox S, Deaton C, Ebrahimi R, Wong P, Singh R, Brown LB, Carter CC, Das M, Baeten JM, Ogbuagu O. Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons. N Engl J Med. 2025 Apr 03; 392(13):1261-1276.
Score: 0.167
-
Landovitz RJ, Hanscom BS, Clement ME, Tran HV, Kallas EG, Magnus M, Sued O, Sanchez J, Scott H, Eron JJ, Del Rio C, Fields SD, Marzinke MA, Eshleman SH, Donnell D, Spinelli MA, Kofron RM, Berman R, Piwowar-Manning EM, Richardson PA, Sullivan PA, Lucas JP, Anderson PL, Hendrix CW, Adeyeye A, Rooney JF, Rinehart AR, Cohen MS, McCauley M, Grinsztejn B. Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial. Lancet HIV. 2023 12; 10(12):e767-e778.
Score: 0.155
-
Neilan AM, Landovitz RJ, Le MH, Grinsztejn B, Freedberg KA, McCauley M, Wattananimitgul N, Cohen MS, Ciaranello AL, Clement ME, Reddy KP, Hyle EP, Paltiel AD, Walensky RP. Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness Analysis. Ann Intern Med. 2022 04; 175(4):479-489.
Score: 0.138
-
Landovitz RJ, Donnell D, Clement ME, Hanscom B, Cottle L, Coelho L, Cabello R, Chariyalertsak S, Dunne EF, Frank I, Gallardo-Cartagena JA, Gaur AH, Gonzales P, Tran HV, Hinojosa JC, Kallas EG, Kelley CF, Losso MH, Madruga JV, Middelkoop K, Phanuphak N, Santos B, Sued O, Valencia Huamaní J, Overton ET, Swaminathan S, Del Rio C, Gulick RM, Richardson P, Sullivan P, Piwowar-Manning E, Marzinke M, Hendrix C, Li M, Wang Z, Marrazzo J, Daar E, Asmelash A, Brown TT, Anderson P, Eshleman SH, Bryan M, Blanchette C, Lucas J, Psaros C, Safren S, Sugarman J, Scott H, Eron JJ, Fields SD, Sista ND, Gomez-Feliciano K, Jennings A, Kofron RM, Holtz TH, Shin K, Rooney JF, Smith KY, Spreen W, Margolis D, Rinehart A, Adeyeye A, Cohen MS, McCauley M, Grinsztejn B. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. N Engl J Med. 2021 08 12; 385(7):595-608.
Score: 0.133
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|